Amyotrophic Lateral sclerosis (ALS) portrays a neurodegenerative condition which possesses substantially inimical actions along with displayed considerable disease heterogeneity at clinical, genetic in addition to neuropathological levels [1,2]. This Amyotrophic Lateral sclerosis name was provided by Jean Martin Charcot -a French neurologist at the time of the 19th century. Amyotrophic implies muscular atrophy-the main property of this disease along with lateral sclerosis referred to the scar production in addition to stiffening of the tissues in the lateral aspect of spinal cord. ALS implicates depletion of lower motor neurons (LMN) of the anterior horn along with brain stem nuclei, in addition to elimination of pyramidal neurons of the primary motor cortex as well as cortico spinal tracts [1].

In Europe as well as North America, ALS incidence rates vary from 1.5-2.7/100,000 population/year, whereas Prevalence rates vary from 2.7-7.4//100,000 population/year; nevertheless, there are significant variations as per geography for instance Portugal possessed the ALS prevalence of 10.3 in 2016 [3]. Amongst the age group possessing maximum risk of ALS generation (45-75yrs), the incidence is amongst 4-8/100,000 population [4]. Till date scarce epidemiological studies have detailed ALS in Spain .A study which was inclusive of Catalonian population revealed an incidence of1.4, along with a prevalence of 5.4/100,000 population/year, Dependent on outcomes obtained in 2011.One more study was performed in Navarra with the utilization of outcomes which had been obtained which was the maximum recent study (acquired uptill 2018), displayed an incidence of 2.47/100,000 population patients, as well as a prevalence of 6.64 /100,000 subjects (95%CI: 4.5-8.25) [5].

Canonically ALS origination takes place at the middle age amongst 55-65 years age .In maximum subjects its manifestation is by propagating muscular atrophy along with weakness. It possesses poor prognosis, with a survival rate 3-5 years from the origination of the symptoms. The most common complications are failure of respiration in view of weakness of the thoracic musculature in addition to aspiration pneumonia secondary to dysphagia. Approximately survival of 20% subjects takes place subsequent to 5yrs of diagnosis along with 5% for≥ 10yrs. ALS is commoner in males (male: female women, men ratio 2:1). In contrast to women, men possess greater risk of generation of sporadic ALS origin; despite there being neutralization of the risk with escalation of age. This propagation of disease ruthlessly results in greater mortality rates. Those patients which are having genetic or bulbar implications possess maximum inimical prognosis [4].

No clarification is present regarding the etiology of ALS in particular however it is thought that generation gets impacted by the correlation with variation of genes in addition to environmental factors [6]. In practically 10% a minimum of a family member is influenced along with referred to as familial ALS (f- ALS), that possesses earlier onset with initiation about 45-60 yrs. of age [1]. The rest of the90-95% subjects take place in the form of sporadic ALS (sALS) that is multifactorial [7].

The pathogenesis of the disease implicates complicated crosstalk of molecular as well as cellular events resulting in neurodegeneration. Glutamate excitotoxicity stimulates cytoplasmic calcium accrual in addition to escalated Oxidative stress (OS). Mutations in the C90RF72, FUS, TDP-43 SOD genes leads to decontrolling of RNA resulting in intra neuronal collection in addition to impairment of axonal transportation. Furthermore microglial activation as well as of neuroinflammation lead to liberation of pro inflammatory cytokines as well as neurotoxicity which further are responsible for neurodegeneration. The combination of these modes comprise the neuropathological signatures of ALS having the properties of depletion of neuromuscular communication, axonal retraction followed by upper motor neurons (UMN) as well as lower motor neurons (LMN) demise [7].

Different theoretical models have been posited regarding the pathophysiological origin of ALS in addition to the modes behind the molecular alterations .This forward model of demise hypothesized that ALS is basically a condition of motor neurons of the cortex, that mono synoptically communicates the neurons in anterior horn of the medulla, modulate the anterograde degeneration of the motor neurons via glutamate excitability.

Cortical hyper excitability has been hypothesized in the form of a pathophysiological event as well as is most likely to be a significant diagnostic biomarker in early stages of disease event. Conversely, the retrograde degeneration posit says that ALS initiation takes place amongst the muscles or neuromuscular junction, once inimical factors once stimulated by free radicals get retrograde shifted from the periphery to the neuronal body, where their toxic actions are stimulated. Lastly, they have posited that mixed degeneration is implicated, with independent along with concurrent implications of both UMN as well as LMN [8].

The maximum frequent clinical kinds is known as spinal ALS having the properties of focal muscle weakness along with atrophy. The striated muscles involvement takes place within mths-scarce yrs. other than the inherent eye muscles ,sphincters as well as heart muscle’s .This weakness in maximum frequently is getting from the distal muscles of extremities - for instance with elimination of strength of either an arm/afoot . Furthermore in view of implications of UMN the manifestation in patients would be in the form of spastic hypertonia, hyperreflexia, motor neurons getting involved in addition to Babinski sign. No sensory implications along with autonomic nervous system dysfunction takes place in ALS [1,8].

Approximately in 25-30% cases more particular presentation is the primary bulbar clinical implications, demonstrating dysarthria, dysphagia, dysphonia, tongue twitching or further scantily masseter weakness. Bulbar initiation has greater prevalence in case of females; is remarkably correlated with cognitive reduction in addition to changed emotional expression as well as usually gets associated with depression. In case of spinal ALS, the evolution of disease events further is associated with bulbar impairment, resulting in joint changes, dysarthria, in view of cranial nerves getting involved [9]. Not enough validation regarding diagnosis of initiation of bulbar kinds in certain patients exists [1,9].

Other clinical phenotypes like primary lateral sclerosis in which the involvement is restricted to UMN. In maximum patients symptoms are initiated in bulbar muscles along with arm, with subsequent leg getting involved. It is debatable if this phenotype actually is inclusive of LMN implications; however greater incidence exists amongst men along with which it usually displays a postponement of initiation. About 30% of patients generate UMN symptomatology amongst 18mthof initiation of disease [8,9].

Despite maximum significant symptoms are the motor ones; 50% of patients with ALS would illustrate extra motor presentation to certain extent. Behavioral alterations or front temporal cognitive deficiencies take place in 35-40% patients, front temporal dementia (FTD) take place in10%. The properties of FTD are degeneration of the anterior temporal in addition to frontal lobes; that clinically manifest in the form of Behavioral alterations as well as dysfunctional executive functions along with language. ALS as well as FTD are currently believed to portray 2 extremes of a spectrum in view of overlap of molecular modes behind both neurodegenerative conditions [1].

Clinical diagnosis of ALS gets made; however no distinctive test exists. Complementary investigations aid in ensuring diagnostic intuition as well as discriminating further pathological conditions [10]. At present ensuring diagnosis unequivocally needs implications of both motor neurons and implications of minimum of 2-4 areas (bulbar, cervical, thoracic, lumbosacral) in addition to differentiating from other causative conditions [10].

A clear cut diagnosis needs a clinical history, neurological examination, as well as complementary investigations. The one that has maximum significance is the electromyography (EMG) that might display support of mild reduction of motor conduction that decreases the amplitude of action potential in addition to continuing muscles undergoing denervation as pointed by the existence of fibrillation potential along with fasciculations existent in numerous muscles in the areas whose examination was performed. Despite EMG observations aid in discrimination of neurogenic atrophies from muscle diseases, certain myopathic events might generate confusion regarding ALS, for instance chronic polymyositis, Pompe disease or multifocal motor neuropathy with blockade of conduction. Canonically genetic investigations is not routinely assessed in ALS .Only in the case of family history of ALS genetic investigations taking into account with regards to presymptomatic diagnosis , though the indication of this investigation remains debatable; at present reserved just for Clinical trials [10].

In view of its multifactorial initiation, accessibility of no efficient treatment is there as per cause. Advancements of pharmacologic trials concentration centered on different modes of actions; for instance methylcobalamin (regarding Oxidative stress (OS) arimocomol (for diminished autophagy), masinitib (a tyrosine kinase hampering agent for prevention of neuroinflammation), tauroursodeoxycholic acid (TUDCA) [an ant apoptosis agent hamperscaspase 3), levosimendan (acts on troponin), gene therapy with tofersen (BIIB067) [for diminishing protein quantities of SOD1) mirror attractive agents which are under scrutiny [10]. Presently Rilutek (R) (with the utilization of glutamatergic hampering agent riluzole in the form of the active constituent) apparently prolongs the survival by 3mths [11], apart from which edaravone (a neuro protective antioxidant as well as mitochondria working agent that has received approval in numerous countries of Asia, in addition to United States, Canada along with Switzerland) are just the drugs whose accessibility is there which possess minimal part in the postponement of clinical outcomes obtained [11,12]. Dependent on the part of OS in ALS pathogenesis evaluation of antioxidants has been done with regards to postponement of initiation of symptoms for instance Vitamin E, Vitamin C, flavonoids resveratrol, curcumin, carotene, as well as melatonin [11].

Till date the mainstay of management of ALS patients continues to be regarding interdisciplinary team care for regulation of symptoms in addition to approaches for enhancement of quality of life (QOL).Out of the symptoms spasticity treatment can be done with baclofen, tinazidine as well as stretching of muscle. Muscle cramps might be responsive to magnesium supplementation, gabapentine or carbamazepine. Selective serotonin reuptake hampering agents, amitryptiline as well as benzodiapenes might be done regarding emotional fragility. Dietary alterations might aidin enhancement of nutritional status as well as a gastrostomy tube is a most likely strategy regarding palliative treatment in patients with inadequate caloric consumption or where swallowing becomes inimical.

One of the reasons of greater mortality rates in ALS is failure of respiration in view of depletion of motor neurons which innervate respiratory muscles for instance diaphragm. Regarding these patients for respiratory failure non invasion mechanical ventilation represents the best treatment in the context of life prolongation; apart from that tracheostomy becomes inevitable in certain instances [13]. For the treatment unique evaluation in addition to more common Interdisciplinary team care as well as patients along with their families awareness of the situation is imperative [1,14].

ALS is a propagative neurodegenerative neuromuscular disease possessing the inimical prognosis. In view of the initiation along with the Clarification of precise etiology of ALS is not there; we only carry out symptomatic therapy as well as life supporting strategies. It became essential to pursue future ALS assessment of its etiology along with its pathophysiological modes for driving towards newer therapeutic strategies for enhancement of survival in addition to symptomatic regulation.

Here this review updates in the context of present hypothesized etiology regarding ALS initiation; going into the genetic as well as environmental factors along with modes which impact motor neurons neurodegeneration. Moreover the probable risk factors which might be providing reasoning with regards to initiation of ALS apart from its spread to motor neurons, for instance neurodegeneration; kinds of physical exercise performed or with regards to intestinal dysbiosis. Neurodegeneration takes place in ALS at greater speed in motor neurons in view of their membrane properties along with their greater energy quantity that predisposes them to greater susceptibility to events secondary to injury by free radicals or glutamate excitotoxicity. On ALS initiation motor neurons having maximum vulnerabilities to neurodegeneration are the type II muscle fibres. Which fatigue at a fast pace. The metabolism of these muscle cells can be hypothesized in the form of the determining factors in the generation of OS which is followed by neuroinflammation which ultimately leads to neuronal degeneration. Furthermore we have taken into account the impact of genetic susceptibility as well as kinds of physical exercise that is practiced might result in>chances of ALS generation. Moreover, here we evaluate the present accessibility of correlation of outcomes with the intestinal microbiota. Lastly we detail the impact of genetic, environmental as well as molecular etiologies of ALS impact the intactness of the enteric nervous system (ENS) positing this as the determining factors in the diagnosis in addition to avoidance of ALS initiation.

Thus a narrative review was carried out using the PubMed, Web of Science, Medline, Embase, Cochrane reviews, and Google Scholar, Search engine with the MeSH Terms; Amyotrophic Lateral sclerosis (ALS); upper motor neurons (UMN); lower motor neurons (LMN) demise; injury by free radicals; glutamate excitotoxicity; oxidative stress; inflammation; Gut Microbiota(GM); Type 1 diabetes (T1D); Familial ALS; Sporadic ALS; enteric nervous system (ENS); from 2000’still date in 2023.

We found a total of 750 articles, out of which we selected 85 articles for this review. No meta-analysis was done.

Causation Factors in Amyotrophic Lateral Sclerosis (ALS)

Clarification of the precise etiology of ALS is totally not revealed. It has been posited that ALS portrays a multifactorial causation having a correlation with genetic, as well as environmental factors implicated in the formation of this disease [15]. Dependent on genetic factors classification of ALS is of 2 kinds i) Familial ii) Sporadic kind. Familial ALS is implicated in 10% of the clinical kinds; along with its pathogenesis is totally secondary to genetic changes. Conversely, maximum of the ALS patients are believed to be sporadic, with no clarification of the causation factors; though it has been posited that it is secondary to an environment gene crosstalk which impacts motor neurons degeneration [16].

Familial Kind ALS

Familial kinds ALS is a hereditary kinds with dominance of autosomal dominant kinds. Autosomal recessive or X linked have further been detailed; however portray the least number of patients. For this kinds of ALS the major risk factor is the family history; along with the production gets stimulated by genetic factors. Mutations of greater than 50 variable genes have been detailed; the maximum evaluated mutations are in the superoxide dismutase (SOD1) gene, TDP43 (RNA binding protein), gene 9 (C9ORF72) as well as fused protein in sarcoma (FUS) that portray 75% of mutations. The commonest mutation is the C9ORF72 gene mutation that is existent in 45-50% of Familial patients [2].

The initial genetic change which was detailed was a mutation in the Cu/Zn correlated superoxide dismutase gene (SOD1) gene present on chromosome 21. Approximately 20% of familial variants of ALS are associated with this mutation; along with 1-2% of the sporadic kind [17]. The cytoplasmic enzyme SOD1 possesses antioxidant effects in addition to is significantly implicated in the body’s defence against inimical oxidant actions. Regulation of SOD1 takes place via its sensitivity to the pressure of oxygen in tissues; that results in stimulation of its actions subsequent to physical exercise in addition to different chemical substances. Immune histochemical evaluation has illustrated that enrichment of SOD1 organization takes place in motor neurons, inter neurons in addition to sensory neurons of the spinal cord. Neurodegeneration can takes place secondary to a mutation in this enzyme in view of of accrual of free radicals in motor neurons with resultant mortality. Changes in this enzyme stimulate cellular events associated with ALS pathogenesis for instance Oxidative stress (OS), neuroinflammation, along with mitochondrial impairment causing changes in the lipid layer of membranes, proteins as well as, DNA of motor neurons [18]. Patients possessing greater mutant SOD1 ALS reveal greater robust LMN degeneration. Apparently there is a greater load of mutated ubiquitinated SOD protein accrual in the LMN as well as greater axonal depletion.

Ubiquitinated TDP-43 inclusions in lesser proportions have been determined in cytoplasm of neurons in both Familial along with Sporadic ALS. TDP-43 delineates a heterogenous nuclear protein implicated for the stability of mRNA, processing, transport as well as translation. In case of normal situations; expression of TDP-43 takes place in numerous tissue inclusive of nuclei of neurons along with glial cells. This gene mutation results in depletion of nuclear TDP-43 in addition to generation of pathological collection in the cytoplasm resulting in neurodegeneration. Noticeably, this event is found apart from ALS in other neurodegenerative conditions for instance Alzheimer’s disease, Lowy body disease as well as front temporal dementia (FTD), suggesting that this cytoplasmic accrual might be correlated with aging in addition to the functional elimination [19].

The other genetic modes responsible for ALS implicates short hexanucleotides expanded sequence repeats (GGGGCC) in the noncoding area of C9ORF72 gene. This gene mutation possesses the properties of TDP-43 proteinopathy, as well as collection of p62 protein are further generated in the neuronal cytoplasm. The p62protein is implicated in the proteosomal pathway as well as autophagy; which has invoked interest with regards to acquisition of insight in the context of how these pathways are implicated in neurodegeneration. Maximum Familial kinds manifest with this kind of mutation [20].

Genetic changes in the gene with regards to FUS protein is determined in3% of the Familial kinds as well as1% of sporadic kinds of ALS. This neuropathological sub kind has the properties of basophilic inclusions in the cytoplasm of the neurons of the motor cortex as well as anterior horn of spinal cord. Despite no clarification is existent with regards to manner by which mutations in FUS result in motor neurons demise, it might portray depletion of working of FUS in the nucleus, or acquisition of toxic working of mutant proteins in the cytosol [2]. Mutations are inclusive of vascular endothelial growth factors (VEGF). The stimulus for initiation of ALS might implicate a difference in the blood flow , generating a non-timely or misplacement of vascular perfusion process which stimulates a molecular pathology which is modulated by “angioneurins” for instance VEGF . Apart from direct neuroprotection, VEGF further possesses an indirect action for sustenance of the blood flow in the spinal cord as well as brain at ideal quantities. Diminished VEGF might result in an inimical reaction to hypoxia; thus to neurodegeneration [21]. Maximum of these genetic factors have been evaluated in European population. In future assessment it is of significance to assess in other populations which belong to other countries [16].

Sporadic Kind ALS

90%of ALS individuals do not have any association with family history; however apparently takes place randomly in patients. In view of no particular stimulators are acknowledged in this disease it is believed to be possessing numerous factors inclusive of crosstalk of genetic (SOD1 along with C9ORF72) as well as environmental factors have been detailed in15% of sporadic kind ALS patients. Here genetic changes are not implicated in stimulating disease; however instead portray predisposition for crosstalk with extraneous factors in the formation of this exaggerated conditions [22].

Elderly /older age, male sex, along with family history are the factors which have been the confirmed risk factors. Conversely, the toxicities of some chemical agents existent in pesticides, metals, cigarette smoking have been hypothesized to be the risk factors which escalate the susceptibility for production of neuronal injury as well as depletion. Furthermore, some electromagnetic waves might lead to motor neurons demise. One more posit implicates viral infections for instance by the human retrovirus K (HERK) which is further controlled by the TDP-43 protein which stimulates cell toxicity [23].

The research that is being performed presently has evoked the probability that physical exercise in the form of a risk factors, in view of its existence in numerous ALS individuals [24], possess some professions commonly for instance being fire fighters ,military workers, along with athletes. Further evaluation of the part of gut Microbiota (GM) might be correlated with the initiation of ALS; apart from if there is implication of enteric nervous system (ENS) through the gut- brain axis might stimulate this disease [25]. Further evaluation of these probable risk factors is imperative for clarification of insight of etiology as well as initiation of ALS [15,23].

Various cellular in addition to molecular events lie beneath ALS generation which result in neurodegeneration followed by motor neurons demise (Figure1).

ALS pathophysiology possesses the properties of change at the level of RNA processing with abnormal in addition to toxic RNA appearing which have depletion of their functionality. The disease further implicates impairment of protein metabolism, hampering of ubiquitin- proteosomal system (SUP), hyper activation of autophagy in addition to aberrations in proteins implicated in axonal transport. Conversely it is believed that neurodegeneration takes place in view of greater quantities of OS in addition to problems encountered in depletion of free radicals or via excitotoxicity developed by glutamate. Lastly changes have been illustrated at the glial cell level (neuroinflammation) that impact motor neurons resulting in their degeneration [16].

Figure 1: Courtesy ref no- 26 in this image, some of the most relevant pathophysiological mechanisms in ALS are described. 1. Alterations in RNA and RNA-binding proteins such as TDP-43 or FUS, leading to aberrant cytoplasmic aggregates. 2. Increased free radicals that damage the motor neuron membrane, DNA, and mitochondria. 3. Alterations in protein degradation. 4. Defects in axonal transport. 5. Neuroinflammation of microglia that influences the progression of neurodegeneration (figure modified from [17]).

Changes in RNA along With Pathological Cytoplasmic Collection

Changes take place in nucleic acid processing; that result in depletion of their functions as well as protein aggregating in the neuronal cytoplasm. The initial observations with regards to such events was the survival geneMN1; that is implicated in messenger pre mRNA along with axonal transport of messenger RNAs to the motor plate region. Following that isolation of mutations in TDP-43 in addition to FUS validated that abnormalities in RNA metabolism might aid in ALS pathogenesis. TARDBP gene mutations that encodes for TDP-43 are scarce etiology of Familial kinds ALS; however cytoplasmic inclusions of this protein are clear in motor neurons in case of Familial along with sporadic kinds. Basically this protein is existent in nucleus as well as crosstalk with DNA along with RNA molecules which influences RNA transcription splicing, followed by transport. Clarification regarding the way these mutations result in ALS generation is not there. At the time of stressful situations TDP-43 works by clustering unnecessary RNA in the cytoplasm; so that just necessary RNA function. Mutations might avoid this protein from conducting its transcription along with RNA processing functions in addition to result in generation of pathological collections in the cytoplasm of the motor neurons [16].

The other gene correlated with the pathophysiology behind ALS in addition to RNA processing is FUS protein gene, implicated in transcriptional control , DNA along with RNA processing along with transport of messenger RNA ‘s. Akin to TDP-43 protein , mutated FUS will generate stress granules in the cytoplasm with incapacity of appropriate functioning. Lastly, mutations in the C9ORF72 gene, results in changed RNA maturation; resulting in generation of depletion of function in addition to toxic gain, with ant accrual in cerebral cortex along with spinal cord [24]. The description of these aggregates is the hereditary kinds; however are further observed in Sporadic ALS as well. They constitute significant aspect of pathophysiological signatures of ALS, where changed RNA leads to elimination of protein functions.

Alterations in the Protein Breakdown System

Neurodegenerative possess the properties of changed protein generation by the endoplasmic reticulum (ER) in addition to changes in the SUP implicated in protein breakdown. ALS is responsible for the cytoplasmic collection of misfolding orabnormal proteins that are implicated in injuring OS in motor neurons impacting motor neurons demise. In case of some cellular stress situations; the ER response is via misfolding of proteins; that are addition to as well as are observed in mouse models as well as ALS cases. The ER gets constituted by ribosomes that are regulated by nucleolus. ALS subjects reveal escalated nucleolus for escalating ribosomal gene generation in case of stress as well as avoidances of accrual of changed proteins [16].

Furthermore, ALS pathophysiology implicates aberrations of the ubiquitin- proteosomal system (SUP) protein breakdown system as well as autophagy. These changes result in elimination of neuronal homeostasis. Regarding motor neurons in the anterior horn of the medulla; patients with ALS illustrate accrual of protein known as ubiquilin 2 which is implicated in protein breakdown. Abnormal packaging as well as impairment of this protein are found in ALS subjects with mutations in ubiquilin 2 in addition to ALS patients without mutations in case of advancements of neuronal degeneration. Moreover it has been revealed that chaperones for instance valos in that are involved in events like proteostasis. These alterations stimulation the of accrual of abnormal protein as well as development of cellular stress [25].

Oxidative stress has been posited in the form of starting factor in the pathogenic generation of ALS. This takes place Subsequent to the rate of Free Radical formation overtakes the changes in the antioxidant capability of motor neuron. Such imbalance amongst Free Radical formation along with foraging them along with results in of motor neurons membrane intactness in view of lipid peroxidation, mitochondrial impairment, changes in protein along with DNA processing as well as excitotoxicity which leads to neuronal demise (see Figure2) [26].

At the intracellular level, maximum production of free radicals takes place by the mitochondrial respiration. Thereby changes in the mitochondrial working further aids in the pathophysiological modes behind ALS. Mitochondrial injury exaggerates Free Radical formation in addition to lipid peroxidation which leads to membrane dedistribution, reduction in adenosine triphosphate (ATP) formation along with dysfunctional DNA healing; thus greater inimical mitochondrial working [28].

Figure 2: Courtesy ref no- 26-Oxidative stress, together with genetic alterations and neuroinflammation, damages mitochondrial dynamics by altering the redox balance, DNA, and calcium and protein balance, leading to neurodegeneration of MNs [28]. MN: motor neurons; ROS: reactive oxygen species; NAD: Nicotinamide adenine dinucleotide; ATP: Adenosine triphosphate; ETC: electron transport chain.

With regards to Familial kinds of ALS the invention of variant in the SOD1 enzymes gene validated this posit regarding free radical toxicity is implicated in the event of motor neurons degeneration. This SOD1 enzymes is implicated in catalysing transformation of toxic superoxide radicals into oxygen (O₂) as well as hydrogen peroxide (H₂O₂) suggesting that it possesses the antioxidant capacity in the aerobic metabolism of motor neurons [16]. Subsequent to mutation depletion of antioxidant capacity of SOD1 might takes place along with aggravate the Oxidative injury via an escalation of prooxidant pathways; thus escalating the OS exposure of motor neurons. In transgenic mice along with human cell lines abnormal SOD1 results in direct stimulation of nicotinamide adenine dinucleotide phosphate reduced form (NADPH) oxidases which leads to over generation of ROS [27].

Noticeably, impairment of SOD1 enzyme is further found in sporadic kinds of ALS. It has been hypothesized that acquiring OS via other modes (for instance pesticides, tobacco exposure) might result in post-translational modifications of the wild kind SOD1 protein, resulting in its misfolding as well as attain toxic characteristics akin to that of mutated SOD1.This modes might be believed to be behind a main stimulator with regards to the pathophysiology behind maximum patients with canonical ALS that are having the absence of pathogenic SOD1 variant as well as probably possesses a crucial part in the inimical propagation of the disorder [7]. Apart from being existent in motor neurons; this changed SOD1is further present in the surrounding astrocytes as well as microglia that impacts the escalation of free radicals in addition to propagation of the injury to motor neurons [25].

It has further been hypothesized that changes in the RNA binding proteins, for instance TDP-43 in addition to FUS might be correlated with mitochondrial impairment; which further facilitates the accrual of free radicals as well as sustenance of OS [6]. Dependent on the molecular events; variable antioxidants have been posited in the form of probable therapeutic substances. For instance melatonin possesses antioxidant capacity as well as can result in reduction of OS quantities [25].This neuroendocrine hormone gets basically generated in the pineal gland as well as illustrates a broad variety of biological actions for instance co of sleep-wake cycle; of metabolism as well as antioxidant, anti-aging along with anti-tumor actions. Melatonin possesses the capacity of avoidances of cell demise, decreasing inflammation, antioxidant enzymes stimulation (like SOD1)) in addition to blockade of Calcium channels implicated in glutamate excitotoxicity [29]. Numerous restriction studies posit melatonin in the form of a newer treatment with regards to tackling OS as well as excitotoxicity in ALS. In mice the antioxidant capacity of melatonin has been evaluated in those having SOD1 mutation as well as in Sporadic ALS patients illustrated 25% diminished disease with escalation of time period of survival from initiation of symptoms in contrast to controls [29]. Nevertheless, future trials are required for confirming the melatonin along with other antioxidant molecules in ALS.

Axonal Transport Abnormalities in Motor Neurons

From the earlier initiation of ALS; patients with illustrated anterograde along with retrograde axonal transport .To start with it was believed that neuronal retraction took place secondary to mitochondrial impairment or the accrual of abnormal proteins; nevertheless present validation displayed mutations in genes that directly encode microtubules regarding axonal skeleton of motor neurons[16]. Profilin gene (PFN1) mutations have further been detailed recently. PFN1 is necessary for polymerization of actin filaments; for instance mutations of this gene result in hampering of axonal growth; escalating the chances of axonal retraction [30]. Changes in the dynactin gene that is implicated in retrograde axonal transport; has been posited as a probable etiology of motor neurons neurodegeneration [28].

Glutamate Excitotoxicity along with Its Association with Apoptosis Sodium

Observations of escalated glutamate confirm the theoretical posit of anterograde production of this disease; which proposes that escalated glutamate receptor quantities start a biochemical stepwise reactions which result in motor neurons demise. It is debatable if glutamate excitotoxicity is the primary pathogenic culprit or is a secondary action to changed motor neuron resulting in escalated glutamate quantities in the postsynaptic cleft. Glutamate portrays the neurotransmitter with maximum enrichment in the central nervous system (CNS). It gets liberation from the presynaptic neurons into the cleft which leads to glutamate getting activated which result in modulation of calcium (Ca₂₊) entry into the postsynaptic neurons; resulting in their depolarization. This is followed by glutamate elimination from the synaptic cleft via excitatory amino acid transporters in an event which is substantially controlled by neurons in addition to glial cells for avoidance of excitability along with toxicity to the motor neurons.

Enhancement of OS quantities as well as changes in the mitochondrial dynamics leads to reduction in the quantities of ATP that result in changed sodium quantities resulting in depolarization in addition to maintenance of neuronal excitability. Enhancement of excitability of motor neurons aids in influx of cytoplasmic calcium as well as mitochondrial impairment, dysfunctional respiratory electron transport chain (ETC), nitric oxide synthase (NOS) activation along with escalated production of toxic radicals. Moreover, it has been acknowledged that glutamate excitotoxicity is implicated in the formation of ROS [31]. Escalated glutamate exaggerates cytoplasmic calcium as well as neuronal excitability. Enhanced calcium results in activation of cytoplasmic lytic enzyme which injure nucleus as well as membrane structures. Actually, in a subset of patients with ALS it has been displayed that a deficiency in AMP-activated protein kinase (AMPK) kind glutamate receptors editing, results in escalated Ca₂₊ permeability [31].

Motor hyper excitability as well as escalated glutamate quantities in cerebrospinal fluid (CSF) as well have been illustrated in patients with ALS [32]. Hyper excitability of the upper motor neurons (UMN) has been acknowledged in ALS; initially by glutamate accrual along with escalation of cytoplasmic calcium quantities followed by propagation to LMN. Glutamate accrual might takes place secondary to aberrant activation of glutamate receptors that leads to escalated Ca₂₊ entry into the postsynaptic neurons resulting in exaggerated neuronal firing. Glutamate excitotoxicity is believed to take place from aberrations in glutamate uptake as well as transporter modes resulting in escalated cytoplasmic Calcium (Ca₂₊), abnormal Ca₂₊ homeostasis; followed by mitochondrial impairment in addition to escalated free radicals generation. Conversely, it has been hypothesized that abnormal glutamate sustenance in the cleft takes place secondary to impairment in astrocytes as well as microglia which have the incapacity of uptake of redundant glutamate. Under normal physiological situations mitochondria would have possessed the capacity of depleting escalated calcium quantities, however in view of changed mitochondrial dynamics these escalated calcium continue to be escalated in the cytoplasm [7]. Excitatory amino acid like glutamate leads to overstimulation of motor neurons that leads toabnormal liberation of acetylcho line esterase which causes reduction of acetylcholine existent in the synaptic cleft; a mode which might lie behind the depletion of strength found in ALS cases [33].

The maximum significant verification of excitotoxicity is implicated in ALS pathogenesis is the finding that just accessibility of Riluzole is there in the form of the treatment presently with regards to this disease. Advancements of ALS stages Riluzole escalates survival by 2-3mths with minimum inimical actions. Different pathways have been proposed for reasoning out its mode of neuronal effects; like hampering of glutamate liberation, glutamate receptors blockade as well as blockade of voltage based sodium receptors in motor neurons [34].

Furthermore, apoptosis might be a late pathway in neuronal degeneration. Escalated free radicals along with escalated cytoplasmic calcium have the capacity of activation of pathways of apoptosis as well as cell demise. Despite debatable, in mouse model studies, the genetic depletion of mitochondrial apoptosis led to diminished neuronal elimination in addition to improvement of ALS symptoms initiation along with survival [35].

Part of Microglia Along With Neuroinflammation in ALS

Neuroinflammation portrays a wide terminology which details the response of glial cells (astrocytes as well as microglia) along with circulating immune cells (monocyte lymphocytes, and neutrophils) which crosstalk with nerve cells in the CNS with regards to infection, damage or degeneration. In case of incapacity of these cells in the depletion of the damage they continue to be responsive along with persistence of enrolment of astrocytes as well as microglia resulting in continued inflammatory event [36,37]. ALS pathogenesis possesses the properties of motor neurons elimination as well as changes however, is further responsible in the inflammatory reactions which is labelled as neuroinflammation by adjacent cells -here astrocytes as well as microglia. Pathological studies have displayed proliferation of glial cells as well as astrocytes in regions influenced by ALS. This inflammatory reaction further impacts propagation of disease as well as motor neurons degeneration. In patients with SOD1 mutation in addition to sporadic kind ALS, astrocytes liberate toxic agents; for instance pro inflammatory cytokines (interleukin-1β (IL-1β) and Tumor necrosis factor alpha (TNFα)] as well as nitric oxide (NO), that injure motor neurons [38]. Furthermore, outcomes in an animal model of experimental autoimmune gray matter disease verified microglial activation with the inflammation modulated toxicity by TNFα as well as IL-1 in addition to UMN/LMN injury. The activation of p38 mitogen activated protein kinase (MAPK) signalling pathway was existent in the generation of motor neurons degeneration [39]. The activation of microglia takes place at the early ALS stages with acquisition of toxic characteristics which aid in neuronal demise. Moreover, changes in the antioxidant enzymes like SOD1 possess the capacity of escalating quantities of free radicals as well as oxidative injury .It has further been pointed that the disruption of blood brain barrier (BBB) in this disease might aid in neurons degeneration [40,41]. There exists an intricate association amongst neuroinflammation with OS in the pathogenesis of neurodegenerative diseases. Astrocytes as well as microglia precipitate escalation of free radicals in addition to motor neurons injury. Despite it has not been clarified if neuroinflammation can be believed to be a primary event in the production of this disease; it is acknowledged to be possessing a part in the propagation of along with flaring up of other pathophysiological events of ALS [36].

In conclusions drawn, the neuropathological signatures of ALS get decided by events for instance; OS, mitochondrial impairment, axonal transport abnormalities, glutamate excitotoxicity along with neuroinflammation. Abnormalities take place which impact free radicals accrual in motor neurons, inclusive of elimination of antioxidant enzymes working like SOD1 along with changes in DNA healing. Enhancement of OS can be escalated by NADPH oxidases activity or dysfunctional mitochondrial respiratory electron transport chain (ETC) activity, secondary to changed mitochondrial dynamics. Conversely, OS along with glutamate excitotoxicity, result in changes in the apoptosis in addition to neuroinflammation generation in the adjacent cells like astrocytes as well as microglia.

Neurodegeneration

Neurodegeneration by definition portrays collection of aberrant events that lead to the misfolding of clusters protein in the cytoplasm of motor neurons which result in Oxidative along with inflammatory injury that results in their demise [40]. In view of the specific properties of motor neurons ALS is responsible for pacey as well as propagation of neurodegeneration in contrast to found in other neuron kinds. Basically motor neurons are larger cytoskeletal cells which need metabolic along with mitochondrial actions. Furthermore they have the properties of having greater readily oxidable polyunsaturated chain fatty acids (PUFA’s) in their membrane. Their greater energy needs as well as membrane properties escalates the predisposition of motor neurons to the actions of Abnormalities of free radicals accrual. Free radicals result in lipid peroxidation, modifications of proteins, mitochondrial impairment, along with changes in DNA in motor neurons that result in greater accrual of these toxic molecules, exaggerating the propagation of ALS neurodegeneration .The escalated free radicals amongst the cells arise from the mitochondria (through respiratory electron transport chain (ETC)], the ER, along with peroxisomes. Partly free radicals generation takes place by enzymes like NADPH Oxidase (NOX). Observation of these enzymes have been illustrated in motor neurons along with neuroglia which are involved in shifting electrons to oxygen in addition to free radicals formation. Free radicals formed in the mitochondrial respiratory ETC might stimulate generation of free radicals in NOX as well as vice versa; implying both modes get stimulate; that propagates neuronal injury. Additionally, these enzymes are controlled by SOD1 which is changed in Familial in addition to sporadic kinds of ALS thus sustenance of enhancement of OS [42]. This kind of enzyme is further present in glial cells that reasons out the part of neuroinflammation along with way by which astrocytes possesses the capacity of forming free radicals which influences neurodegeneration. There are different variable kinds of NOX isoforms. Mice having ALS illustrated NOX type2 enzyme; in addition to its hampering improves propagation of symptoms [43,44].

The Sporadic kinds of ALS; OS can be formed by the crosstalk of different extrinsic factors; for instance metal exposure, smoking enhance pro oxidant pathway ; that result in accrual of free radicals. This event along with proneness of motor neurons as well as lesser capacity of get renewed, in motor neurons tobe injured along with undergo demise.

Initiation of neurodegeneration can takes place at any juncture of the pyramidal pathway. It might takes place concurrently in UMN/LMN subsequent to the posit of mixed dis production which verifies that is an independent event originating in full motor neurons concurrently.

Association of the Intensity of Physical Activity Along With Muscle metabolism

The group of Van den Berg contrasted the lifestyle of 1557 subjects that had been diagnosed with ALS in Europe vs 2922 healthy subjects [45]. Their observations illustrated that subjects that had been diagnosed with ALS possessed greater the greater probability of taking part in robust physical exercise with subjects who performed greater exercise possessed greater chances(26%)of generating ALS in contrast to subjects having lesser activity [45,46]. Noticeably, some professions commonly for instance being fire fighters, soccer players [47], military workers [48] along with athletes, might have susceptibility of generating ALS. An escalated risk of ALS was further observed in those with greater activity with regards to entertainment/pleasure time [49]. This way absence of correlation with the physical activity related to their occupation further validated the posit with regards to a genetic profile or lifestyle which facilitates physical fitness escalates predisposition to ALS instead of physical activity by itself [49]. Conversely, different publications evaluated the way the intensity of physical activity done might stimulate OS started in the muscle fibres; that has implications on neurodegeneration of the motor neurons which are implicated in the innervation of these muscle fibres.

The classification of skeletal muscle fibres is as per fast twitch (type II a, II b as well as II x) or slow twitch (type I) muscle fibres as per their metabolic along with functional characteristics. In the case of ALS the motor neurons which are implicated in the innervation of type II b muscle fibres - meaning which innervate fast fatiguing fibres that are implicated in anaerobic burst action-are the ones that have maximum susceptibility to the disease event [21].

The transgenic mouse model which are carrying SOD1 mutation reveal diminished contraction along with elimination of motor units in the hind limb muscles which possess greater proportion (>90%) of type II muscle fibres. This is in agreement with other observations illustrating that motor neurons which innervate type II b muscle fibres undergo degeneration prior to slow fibres are impacted [50]. One more study in mice which are SOD1 mutant displayed changes in the muscle performing in slow as well as fast twitch muscles indicating that muscle fibres susceptibility is a sequel of the kind of motor neurons innervating these muscle fibres instead of the muscles metabolism [46].

The motor neurons that have maximum susceptibility to ALS pathogenesis are the ones innervating muscle fibres that have anaerobic metabolism .These muscle fibres are implicated in the faster contraction along with fatigue at a fast pace in addition have been specialized for robust physical exercise like in a 400m sprint race. This metabolism needs plenty of energy being acquired in the lack of oxygen whose acquisition takes place via anaerobic glucose breakdown generating energy as well as lactic acid. Lactic acid generally gets depleted or gets oxidized by the muscles. Enhancement of lactic acid might stimulate the conversion of free radicals generation which is not very inimical (superoxide radical) into a one which is a substantially inimical free radical (perhydroxyl radical) in view of the crosstalk of the superoxide radical with protons obtained from lactic acid [51]. Subjects conducting strenuous physical activity possessed greater proneness for rapid lactate production that results in escalated OS which leads to neurodegeneration as well as neuronal demise in the neuromuscular unit along with sequentially in motor neurons. Numerous studies have illustrated that free radicals possessed significant part in the form of the modulators of muscles injury along with inflammation generate in view of robust physical exercise. Furthermore, escalated lactate can stimulate mitochondrial impairment in motor neurons that produces escalated OS [46]. These observations confirmed that ALS production would be likely to be a retrograde transportation at the initiation at the level of motor unit. Here the initiation of injury might takes place at the LMN which is implicated in the innervation of this kinds of muscle fibres. With the propagation taking place to UMN, that is the manner that originating symptomatic presentation takes place in maximum of canonical ALS subjects. At the time of early disease the symptoms which occur are just muscle weakness along with atrophy, probably pointing to injury to the LMN which innervate these kinds of fibres. Propagation of the disease leads to symptoms of the UMN injury for instance spasticity, hypertonia, as well as hyper reflexia.

The posit with regards to extent of physical activity performed might be a stimulus for ALS gets further validated by the statistics of 52% of clinically confirmed ALS of clinically correlated genes get differentially expressed subsequent to acute exercise inclusive of C9ORF72 gene [52]. C9ORF72 gene down regulation at the time of physical exercise might work in synergism by escalating toxicity in motor neurons. Genes associated with Fibroblast growth factor (FGF) along with nerve growth factor (NGF) signalling might be changed. Considerable expression of FGF is feasible by OS, hypoxia as well as hypervolemia, for induction of activation of astrocytes. FGF along with NGF get generated by astrocytes in particular situations in vitro as well as this signalling has been illustrated to stimulate apoptosis in particular situations in vitro, along with this signalling has been held responsible for ALS pathophysiology [52]. Actually, the propagation of neuronal degeneration might be secondary to continued stimulation by FGF or SOD modulated OS in astrocytes [53]. It is feasible that physical activity might be an ALS stimulating factor in those having genetic predisposition. For instance in patients with genetic changes in C9ORF72, the ALS phenotype might be lesser exaggerated in those with prior history of lesser physical activity in contrast to patients with history of prior intense physical activity [52]. Thus positing that ALS might be originating from the generation of OS in the neuromuscular junction, in the form a sequel of the of strenuous physical activity; aids in generation of advocation for subjects possessing genetic proneness to ALS generation as well as aid in counselling with regards to their lifestyle along with kind of physical activity they need to perform with objective of decreasing their disease propagation.

Intestinal Dysbiosis Along With Implication of Enteric Nervous System (ENS)

The Gastrointestinal Tract (GIT) is home for trillions of microorganisms which in toto is labelled as the gutmicrobiota (GM) that is given a shape by host genetics in addition to environmental exposure. Earlier we had reviewed the part of GM in the aetiopathogenes is of obesity, Type 1 diabetes mellitus (T1D), Non-alcoholic Fatty Liver Disease (NAFLD) / Non-alcoholicsteato hepatitis (NASH), Osteoarthritis along with role in Neuropsychiatric Diseases, and the part of mitochondrial transport in Etiopathogenesis and management of various CNS diseases generation [54-62]. Escalated proof has verified the posit of microbiota- gut- brain axis [63] which we further validated in case of importance of Dysbiosis in intestinal flora Subsequent to ischaemic Stroke[ rev in ref [64,65]. Via this axis GM modulate partially the central nervous system (CNS), as well as peripheral nervous system (PNS) [63]. Dependent on this axis it has been posited that Intestinal microorganisms possess the capacity of impacting the CNS either via the generation of neuroactive metabolites liberated into the systemic circulation or via ENS or cranial nerves like the vagus [66,67]. Thereby alterations in diet/ infection might influence positively or negatively the neuropathological as well as behavioural phenotypes of any disease.

Aging is associated with alterations in the intestinal Microbiota that stimulates systemic inflammation [68]. Despite, no availability of numerous studies in humans along with animal models have been specifically of use in illustrating the way Microbiota impacts aging. For instance over growth of Lactobacillus planetarium has been correlated with reduction in lifespan in, view of escalated generation of oxygen free radicals impacting the ENS [69]. Moreover faecal Microbiota transplantation (FMT) from young mice to aged ones have been conducted which displayed young mouse Microbiota confers protection [70].

Contrasting of GM constitution has been performed in ALS patients with healthy controls. Metagenomic sequencing of the gut micro biome has displayed a significantly different microbial constitution in ALS patients in contrast to healthy controls with ALS patients illustrating escalated enrichment of Anaerostipes hadrus, Bacteroidales bacteria along with Bi fidobacterium pseudocatenulam in association with minimally reduction in enrichment of Clostridium leptum in addition to Escherichia Coli (E. coli) [71]. Nevertheless, other studies demonstrated variations in organization of such bacteria or no significant variations in the intestinal microbial constitution amongst ALS patients as well as healthy controls. These debatable outcomes from different studies might be partially in view of restricted power of studies emphasizing the requisition of systematic assessment of microbiota in larger cohorts of ALS patients as well as healthy controls.

Furthermore, the probability of changes in the Microbiota have been evaluated in case of SOD1 mutant transgenic mice. In contrast to wild kind littermate mice, SOD1 mutant mice illustrated a uniquely variable microbiome constitution prior to initiation of motor dysfunction as well, pointing that changes in gut microbiome of SOD1 mutant mice were not subsequent to motor impairment [72]. There is clarification regarding formation of dysbiosis takes place even before the initiation of symptoms. Furthermore, SOD1 mutant mice revealed a greater intestinal transition time (from consumption of food till its faecal depletion) which takes place parallel to the initiation of weakness in limb muscles [73]. This greater intestinal transition time implies slower intestinal motility. Greater findings are inclusive of diminished smooth muscle myosin heavy chain (SMMHC) as well as glial fibrillary acidic protein (GFAP) suggesting enteric injury [64] akin to the manner in which reactive astrocytes in the CNS reveal hypertrophic nuclei along with cell bodies in addition to escalated elaborated events with enhancement of GFAP [53]. In a recent study manipulation of microbiome in ALS with utilization of metronidazole as well as clindamycin in the form of the antibiotics in addition to butyrate as postbiotics observed diminished human- SOD1 G93A clusters, reduced expression of GFAP as well as escalated SMMHC expression in the intestines along with lumbar spine of SOD1 G93A mice with antibiotics. With the utilization of postbiotics these outcomes were found in the intestines along with lumbar spine with reduction of human- SOD1 G93A clusters as well as expression of GFAP. These outcomes pointed that impairment of intestinal micro biome might be correlated with impairment of skeletal muscle action along with on motor neurons in ALS [73].

Moreover, the initiation of ALS might be correlated with communication amongst CNS in addition to ENS. The cytoplasmic accrual of phosphorylated TDP43 ((pTDP43) clusters in the CNS [74] of sporadic ALS (sALS) along with maximum genetic ALS have been illustrated amongst muscles [75] in addition to peripheral nerves biopsies [76]. Astonishingly, a recent study on surgical colonic biopsies [67] have illustrated pTDP43 clusters amongst the lamina propria (mucosal connective tissue deep to the surface enterocytes) as well as the myenteric plexus. Thereby the query arises -what is the manner by which a pathology that gets initiated in the gut manages to arrive in the CNS, or is it taking place concurrently in both places. The existence of p TDP43 clusters amongst intestinal tissue points that probably akin pathological modes are implicated in the transfer which is found in other neurodegenerative diseases [77]. Dysbiosis might be implicated in the stimulation of neurodegeneration of the neurons of the ENS. The ENS is intricately placed with motor neurons which arrive at the spinal cord as well as cranial nerves like the vagus. Thereby intestinal dysbiosis might further validate the retrograde posit of disease formation. The dysbiosis generated in SOD1 mutant mice was inclusive of diminished Akkermansia muciniphilia in contrast to wild kind littermate. Colonization of antibiotics treated SOD1 mutant mice with A. muciniphilia resulted in escalation of longevity, abrogated their brain atrophy along with motor deficiency in addition to escalation of quantities of nicotinamide [62]. Nicotinamide portrays a kinds of Vitamin B3 along with is a part of the metabolic pathway responsible for energy generation in cell. Clarification regarding the manner this metabolite attenuates ALS symptoms is not there; however it might be associated with diminished OS in the nervous system as well as modulation of mitochondrial genes present in the spinal cord [78]. The protection conferred by A. muciniphilia is probably in view of manipulation of metabolites-here nicotinamide which get liberated from the blood to the brain hence conferring protection to the motor neurons from neurodegeneration. The observations in transgenic mice have got validated with the mapping of human microbiota that revealed with regards to ALS patients which possess lesser percentage of A. Muciniphilia along with reduced nicotinamide in contrast to subjects without ALS [72].

Besides metabolites generation, mice possessing changed Microbiota further revealed abnormal as well as microglia that have dysfunctional working in view of formation of peripheral inflammation [79]. This suggests, for instance significantly diminished butyrate generating bacteria in SOD1 mutant mice. Butyrate generating bacteria are acknowledged to possess significant part in the regulation of the intestinal inflammatory events, the maturation of the immune system in view of short chain fatty acids (SCFA) butyrate leads to inactivation of lymphocytes maturation [80].

Studies regarding mouse model have illustrated that alterations in Microbiota might result in enhancement of the disease phenotype (like motorsymptoms), despite these observations continue to be just experimental. Alterations in the intestinal the Microbiota, dysfunctional permeability along with systemic inflammation might portray the maximum early events which stimulate ALS pointing that intestinal dysbiosis with impacted ENS might work in the form of the factor implicated in conditioning the ALS origination as well as modulation of ALS propagation [81].

Figure 3: Courtesy ref no-26- Relationship of alterations in the intestinal microbiota and enteric nervous system with neuroinflammation and neurodegeneration of the CNS, through the connection of the intestine-brain axis CNS: central nervous system (figure modified from 82]).

Role of Crosstalk of Astrocytes, Gut Micro biome, Muscle With in ALS through Mitochondrial Melatonergic Pathway

The pathoetiology as well as pathophysiology of motor neuron depletion in amyotrophic lateral sclerosis (ALS) are still to be detected, with just a small proportion of ALS patients having an acknowledged genetic risk factor. Recently AndersonG [83], reviewed with an attempt of integration of greater outcomes obtained along with on the biological corroboration of ALS, emphasizing the integrative part of alterations in the mitochondrial melatonergic pathways along with systemic factors controlling this pathway over multiple key pivots/centre points in ALS pathophysiology, for instance glia, gut, along with the muscle/neuromuscular junction. It is posited that repression of the mitochondrial melatonergic pathway verifies alterations in muscle brain-derived neurotrophic factor (BDNF), along with its melatonergic pathway simulate, N-acetylserotonin, resulting in absence of metabolic trophic support at the neuromuscular junction. The amelioration of the melatonergic pathway in astrocytes avoids activation of toll-like receptor agonists-induced pro-inflammatory transcription factors, NF-kB, as well as yin yang 1, from possessing a built-in restriction on inflammatory stimulation that gets initiated from their synchronized stimulation of melatonin. This kind of maintained astrocyte activation, coupled with escalated microglia responsiveness, is a significant driver of motor neuron proneness in ALS. Two significant systemic factors, gut dysbiosis/permeability as well as pineal melatonin mediate many of their advantageous action effects via their capacity to up regulate the mitochondrial melatonergic pathway in central as well as systemic cells. The mitochondrial melatonergic pathway might be visualized in the form of a core aspect of cellular function, with its repression escalating reactive oxygen species (ROS), resulting in ROS-induced microRNAs, therefore changing the designing of genes stimulated. It is posited that the escalated occupational risk of ALS in farmers, gardeners, and sportsmen as well as women is intricately correlated with exposure, whereas being physically active, to the widely utilized glyphosate- adependent based herbicides [83]. This has multiple research along with therapeutic implications [rev in ref83 -earlier we had reviewed the role of ovarian mitochondrial melatonergic pathways in ovarian ageing for DOR&SIRT signalling [84].

Figure 4: Courtesy ref no- 83 this figure shows how tryptophan (light blue shade) can be utilized for beneficial (green) or detrimental (orange) effects in ALS. Tryptophan is converted to serotonin in astrocytes by tryptophan hydroxylase (TPH) 2 which has been stabilized by 14-3-3e. Serotonin is converted by AANAT to N-acetylserotonin (NAS) when stabilized by another 14-3-3 isoform and in the presence of acetyl-CoA as a co-substrate. NAS is converted by ASMT to melatonin. NAS can activate the BDNF receptor, TrkB, as well as induce BDNF, whilst melatonin has antioxidant, anti-inflammatory, and mitochondria-optimizing effects. However, in the presence of pro-inflammatory cytokines and stress-associated cortisol-induced IDO and TDO, respectively, tryptophan is converted to kynurenine, which can activate the AhR leading to a number of detrimental effects via kynurenine pathway products that drive excitotoxicity. However, when an active melatonergic pathway is present, AhR-induced CYP1B1 can ‘backward’ convert melatonin to NAS, thereby increasing TrkB-FL activation and BDNF induction. Abbreviations: AANAT: aralkylamine N-acetyltransferase; AhR: aryl hydrocarbon receptor; ASMT: N-acetylserotonin O-methyltransferase; CYP: cytochrome P450; IDO: indoleamine 2, 3-dioxygenase; KAT: kynurenine aminotransferase; NAS: N-acetylserotonin; TDO: tryptophan 2, 3-dioxygenase; TPH2: tryptophan hydroxylase.

Figure 5: Courtesy ref no- 83 this summary figure shows how many ALS-linked factors can impact mitochondrial function, with relevance across different cell types. Gut dysbiosis is highlighted in green, whilst muscle-NMJ-MNs loss is highlighted in yellow. Gut permeability-associated LPS activates TLR4/NF-kB/YY1 to drive maintained astrocyte activation in the presence of a suppressed melatonergic pathway. The shikimate pathway produces tryptophan (as well as tyrosine and phenylalanine) to drive the serotonin/NAS/melatonin pathway, which requires different 14-3-3 isoforms and acetyl-CoA to be functional. A number of factors can ‘backward’ convert melatonin to NAS, including P2Y1r, mGluR5, and AhR activation. NAS can be beneficial in ALS as it is a BDNF inducer and activator to TrkB-FL. The AhR may also have detrimental effects via 14-3-3 suppression, as well as increasing TDP-43. Gut dysbiosis and pro-inflammatory cytokine suppression of pineal melatonin suppress the capacity of butyrate and melatonin to disinhibit PDC and the PDC conversion of pyruvate to acetyl-CoA, which is a necessary co-substrate of AANAT in the conversion of NAS to melatonin. The suppression of the melatonergic pathway leads to increased oxidants, decreased endogenous antioxidants, OXPHOS, and sirtuins, thereby increasing mitochondrial ROS, ROS-inducing miRNAs, and altered gene patterning, which is a major driver of ALS pathophysiology. The maintained activation of astrocytes decreases neuronal GSH, synapses, and EAAT2 whilst increasing amyloid-β and hyperphosphorylated tau, all of which contribute to ROS-driven changes in patterned miRNAs and gene inductions. The loss of muscle BDNF leads to suboptimal mitochondrial function at the NMJ and MNs loss. All these changes comprise the biological underpinnings of ALS. GBH can have multiple negative impacts, as indicated by points across the figure. Abbreviations: AANAT: aralkylamine N-acetyltransferase; AhR: aryl hydrocarbon receptor; ASMT: N-acetylserotonin O-methyltransferase; BDNF: brain-derived neurotrophic factor; Bmal1: basic helix-loop-helix ARNT Like 1; CYP: cytochrome P450; EAAT: excitatory amino acid transporter; GBH: glyphosate-based herbicides; IDO: indoleamine 2,3-dioxygenase; LPS: lipopolysaccharide; mGluR5: metabotropic glutamate receptor 5; mito: mitochondria; MNs: motor neurons; NAS: N-acetylserotonin; NF-kB: nuclear factor kappa-light-chain-enhancer of activated B cells; NMJ: neuromuscular junction; OXPHOS: oxidative phosphorylation; P2Y1r: purinergic 2Y1 receptor; PDC: pyruvate dehydrogenase complex; ROS: reactive oxygen species; SIRT3: sirtuin-3; TDO: tryptophan 2,3-dioxygenase; TDP-43: transactive response DNA binding protein 43kDa; TLR: toll-like receptor; TPH2: tryptophan hydroxylase; TrkB-FL: tyrosine receptor kinase B-full length; TrkB-T1: tyrosine receptor kinase B-truncated; YYI: yin yang 1.

Part of Bile Acids in Neuroinflammation, ER Stress- and How TUDCA Might Benefit in ALS

Bile acids (BA) are significant physiological molecules that apart from modulating nutrients absorption as well as metabolism in peripheral tissues, possess neuromodulation actions in the central nerve system (CNS). The catabolism of cholesterol to BA takes place basically in the liver by the canonical along with alternative pathways, or in the brain started by the neuronal- particular enzyme CYP46A1 modulated pathway. Circulating BA could cross the blood brain barrier (BBB) as well as arrive at the CNS via passive diffusion or BA based transporters. Brain BA might trigger direct signal via activating membrane along with nucleus receptors or impacting activation of neurotransmitter receptors. Peripheral BA might further provide the indirect signal to the CNS through farnesoid X receptor (FXR) fibroblast growth factor 15/19 (FGF15/19) pathway or take da G protein coupled receptor 5 (TGR5) based glucagon-like peptide-1 (GLP-1) pathway. Under pathological conditions, changes in BA metabolites have been invented in the form of probable pathogenic contributors in multiple neurological conditions. Hydrophilic ursodeoxycholic acid (UDCA), particularly taurour so deoxycholic acid (TUDCA) are promising as can impact neuroprotective part by ameliorating neuroinflammation, apoptosis, oxidative or endoplasmic reticulum stress, which provides promising therapeutic actions for treatment of neurological diseases. Thereby Xing [85], reviewed recent observation emphasizing the metabolism, crosstalk between brain along with periphery, as well as and neurological functions of BA to establish the significant part of BA signalling in the brain in case of both physiological in addition to pathological conditions [85] (See Fig 6 and 7).

Figure 6: Courtesy ref no- 85 Metabolism and circulation of bile acids in periphery and brain. The catabolism of cholesterol to primary bile acids (BA) in liver by two pathways, involving the critical enzymes cholesterol 7α-hydroxylase (CYP7A1) and sterol 12α-hydroxylase (CYP8B1) in the classical pathway to form cholic acid (CA), and sterol 27-Hydroxylase (CYP27A1) and oxysterol 7α-hydroxylase (CYP7B1) in the alternative pathway to synthesize chenodeoxy cholic acid (CDCA). The neural cholesterol clearance pathway is initiated by CYP46A1 to form 24(S)-hydroxy cholesterol (24-OHC) from cholesterol. 24-OHC subsequently crosses the BBB, and is metabolized by CYP39A1 in the liver to synthesize CDCA. The brain 27-OHC converted by CYP27A1 might also cross the BBB and is metabolized by CYP7B1 in the liver. The primary BA are converted to conjugated forms with glycine or taurine. Then, primary BA are further converted to the secondary BA metabolized by the gut microbes. After re-absorption through passive diffusion or bile acid transporters, about 95% of BA are reabsorbed in the ileum and returns to enterohepatic circulation. A small amount of BA in the systemic circulation can be taken up into the brain by passive diffusion or by active transport through the blood brain barrier (BBB).

Figure 7: Courtesy ref no- 85 Bile acids signal to the central nervous system (CNS). Bile acids (BA) in the intestinal lumen can signal to the CNS via the direct pathway or indirect pathway. Bile acids in the intestine escape the enterohepatic circulation, reach the systemic circulation, and cross the blood-brain barrier (BBB) to interact with receptors in the brain. BA in the CNS could exert an anorexigenic effect via activating TGR5 in the hypothalamic arcuate nucleus or block GABAA receptor on tuberomammillary nucleus (TMN) of the hypothalamus to promote wakefulness. BA taken up by enterocytes can activate the nuclear receptor FXR to promote FGF15/19 production. FGF15/19 is released by the enterocytes, enters the systemic circulation, and cross the BBB to interact with FGF receptors in the brain. The central effects of FGF15/19 are involved in glucose metabolism and energy homeostasis. TGR5 activation by BA in enteroendocrine L-cells triggers GLP-1 production. GLP-1 could interact with GLP-1 receptors expressed on afferent terminals of the vagal nerve present in the lamina propria and portal vein. The vagal nerve projects to the brainstem, from where projections are further directed toward other brain regions. GLP-1 is believed to exert its inhibitory effect on food intake and energy homeostasis via the vagal-brainstem-hypothalamic pathway

ALS portrays the commonest neurodegenerative motor neurons diseases which possesses substantially deleterious prognosis. Acquisition of greater insight in the pathophysiological modes in addition to initiation of the disease is the requirement for attainment of newer diagnostic along with therapeutic approaches for enhancement of survival as well as quality of life (QOL) of patients with ALS.

The commonest kind is the sporadic kind (90%) whereas just 10% take place secondary to genetic changes in Familial kind. The so far acknowledged etiology in case of Sporadic kind is believed to be multifactorial probably implicating some kind of genetic predispositions along with correlation with the variable risk factors.

The pathophysiology of ALS is inclusive of RNA processing, protein metabolism, abnormalities as well as breakdown of protein along with escalation of axonal transport abnormalities in motor neurons that result in cytoplasmic protein aggregates, stimulating intracellular OS as well as neurodegeneration of motor neurons. Changes in mitochondrial dynamics, neuroinflammation, glutamate excitotoxicity, exaggerate Oxidative injury in motor neurons, producing changes in membranes, proteins, as well as DNA that result in neuronal demise. The current anterograde posit, hypothesized the primary implications of UMN in view of hyper excitability of glutamate. The mixed posit pointed to the probability of other etiologies which in synergism impact UMN in addition to LMN for instance neurodegeneration.

The retrograde postulates regarding ALS precipitation takes place by numerous factors correlated with genetic predispositions as well as intestinal dysbiosis with implications of enteric nervous system (ENS). Furthermore the association of crosstalk amongst Astrocytes, Gut Micro biome, and Muscle within ALS through Mitochondrial Melatonergic pathway and disturbance by glyphosate based herbicides is needed to be explored. These all are significant insight regarding remarkable utilization in addition to future clinical assessment of ALS.

In view of variable kinds of probable etiologies responsible for ALS pathogenesis, the ongoing pharmacologic trials will be the deciding factors for the manner to proceed for attaining greater understanding with regards to further prognostic escalation in addition to survival.

Just akin to numerous diseases which are refractory to therapies, it is essential to point that it would be enough to evaluate those situations implicated in disease precipitation particularly the escalating attraction of gene therapies along with requirement of implementing the requisite genetic studies in susceptible subjects.

1. Masrori P, Van Damme P. Amyotrophic Lateral sclerosis: a clinical review. Eur J Neurol. 2020; 27: 1918-1929.
2. Brown RH Jr. Amyotrophic Lateral sclerosis and motor neurons diseases. In Harrison’s Principles of Internal Medicine. 20^th Edition; Fauci AS, K DL, L DI, Braunwald E, Hauser SL, Jameson JL, Eds: M cGraw Hill: NewYork, NY, USA. 2018; 2: 141-147.
3. Conte B, Winck JC, Azevedo LF. Estimating Amyotrophic Lateral sclerosis and motor neurons diseases Prevalencein Portugal using a Pharmaco- epidemiological approach and a Bayesian multi parameter evidence synthesis model. Neuroepidemiology. 2019; 53: 73-83.
4. Castro Rodriques E, Azagre R, Gomez Batiste X, Provedano M. Amyotrophic Lateral sclerosis (ALS) primary care epidemiology and Clinical care characteristics. Aten Primaria. 2021; 53: 102158.
5. Jerico I, Elizalde Beiras I, Pagola I, Torne L, Galbete A, Delfrado-Osinaga J, et al. Clinical features and incidence trends of Amyotrophic Lateral sclerosis in Navarre, Spain 2007-2018: a population based study. Amyotrophic Lateral scler Front Degener. 2021; 22: 401-493.
6. Nowicka N, Juranek J, Juranek JK, Wojtkiewicz J. Risk factors and emerging therapies in Amyotrophic Lateral sclerosis. Int J Mol Sci. 2019; 20: 2616.
7. Mezini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS genetics, mechanisms and therapeutics. Where are we now?. Front Neurosci. 2019; 13: 1310.
8. Grad LL, Rouleau GA, Ravits J, Cashman NR. Clinical spectrum of Amyotrophic Lateral sclerosis (ALS). Cold Spring Harb Perspect Biol. 2017; 7: a024117.
9. Elman LB, Mc Cluskey L. Clinical features of Amyotrophic Lateral sclerosis and other forms of motor neurons diseases: uptodate Inc; Waltham MA, USA. 2021; 31: 1.
10. Elman LB, Mc Cluskey L. Diagnosis of Amyotrophic Lateral sclerosis and other forms of motor neurons diseases: uptodate Inc; Waltham MA, USA. 2021.
11. Chio A, Mazzini L, Mora G. Disease modifiying the rapies in Amyotrophic Lateral sclerosis. Neuropharmacology. 2021; 167: 107986.
12. Sever B, Ciftci H, DeMirci H, Sever H, Ocak F, Yulug B, et al. Comprehensive researchon past and Future therapeutic strategies devoted to treatment of Amyotrophic Lateral sclerosis. Int J Mol Sci. 2022; 23: 2400.
13. Carrera Julios S, Moreno ML, Barrios C, DeLa Rubia Orti JE, Drehmer E. Antioxidant alternatives in the treatment of Amyotrophic Lateral sclerosis:a Comprehensive review. Front Physiol. 2020; 11: 63.
14. Ng L, Khan F, Young CA, GM. Symptomatic treatment of Amyotrophic Lateral sclerosis/ motor neurons diseases. Cochrane Database Syst Rev. 2017; 1: CD011776.
15. Danel Brunaud V, Touzet L, Chevalier L, MoreauC, Devos D, Vandolaeghe S, et al. Ethical considerations and palliative care in patients with Amyotrophic Lateral sclerosis: a review. Rev Neurol. 2017; 173: 300-307.
16. Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for Amyotrophic Lateral sclerosis. Clin Epidemiol. 2015; 7: 181-193.
17. Riancho J, Gonzalo I. Ruiz-Soto M, Bercano J. Why do motor neurons degenerate?. Actualization in the pathogenesis of Amyotrophic Lateral sclerosis. Neurologia. 2019; 34: 27-37.
18. Kaur SJ, Mc Keown SR, Rashid S. Mutant SOD mediated pathogenesis of Amyotrophic Lateral sclerosis Gene. 2016; 577: 109-118.
19. Al Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol. 2013; 9: 617-628.
20. Prasad A, Bharathi V. Sivalingam V, Girdhar A, Patel BK. Molecular mechanisms of TDP-43 misfolding and pathology in Amyotrophic Lateral sclerosis. Front Mol Neurosci. 2019; 12: 25.
21. Balendra R, Isaacs AM. Corf 72- mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol. 2018; 14: 544-558.
22. Ravits JM, La Spada AR. ALS phenotype heterogeneity, focality and spread: deconstructing motor neurons degeneration. Neurology. 2009; 73: 805.
23. Van Es MA, Hardiman O, Chio A, Al Chalabi A, Pasterkamp PJ, Veldink JH, et al. Amyotrophic Lateral sclerosis. Lancet. 2018; 390: 2084-2098.
24. Lacorte E, Errigno FL, Leoncini F, Corbo M, Boccia S, Vanacone N. physical activity and physical activity related to sports, leisure and occupational activity as risk factors for ALS: A systematic review. Neuro Sci Bio behav Rev. 2016; 66: 61-79.
25. Obrenovich M, Jaworski H, Tadimalla T, Mistry A, Sykes J, Perry G, et al. The role of microbiota- gut- brain axis and antibiotics in ALS and neurodegenerative diseases. Microorganisms. 2020; 8: 74.
26. Pingarron LL, Almeida H, Soria Aznar M, Reyes-Gonzalez MC, Terron MP, Garcia JJ. Role of Oxidative stress on the pathophysiology of Amyotrophic Lateral sclerosis (ALS) and its relation with enteric nervous system. Curr Issues Mol Biol. 2023; 45: 3315-3332.
27. Furtado-Batos A, Orsini M, Machado D, Mello MP, Nader S, Silva JG, et al. Amyotrophic Lateral sclerosis:one or many causes?. Neurol Int. 2011; 3: e4.
28. Obrador E, Salvador-Palmer, Lopez-Blanch R, JihadJebbar A, Valldes SL, Estrela JM. The link between Oxidative stress, Redox status, bioenergetics and mitochondria in the pathophysiology of ALS. Int J Mol Sci. 2021; 22: 6352.
29. Majourie E, Renton AE, Mok K, Dopper EGP, Waite A, Rollinson S, et al. Frequency of the Corf72- hexanucleotides repeat expansion in patients with Amyotrophic Lateral sclerosis and frontotemporal dementia: a cross sectional study. Lancet Neurol. 2012; 11: 323-330.
30. Williams KL, Warraich ST, Yang S, S JA, Fernando R, Rouleau GA, et al. UBQLN2/ ubiquitin 2 mutation and pathology in Familial Amyotrophic Lateral sclerosis. Neurobiol Aging Neurol. 2012; 33: 2527. e3-2527.e10.
31. Weishaupt JH, Bartels C, Polking E, Dietrich J, Rohde G, Poegler B, et al. Reduced Oxidative damage in ALS by high dose enteral melatonin treatment. J Pineal Res. 2006; 41:313-323.
32. Hayashi Y, Homma K, Ichijo H. SOD1in neurotoxicity and its controversial roles in SOD1mutation negative ALS. Adv Biol Reg. 2016; 60: 95-104.
33. Pandi-Perumal SR, Ba Hammam AS, Brown GM, SDW, Bharathi VK, Kaur C, et al. Melatonin antioxidative defense: therapeutic implications for aging and neurodegenerative processes. Neurotox Res. 2013; 23: 267-300.
34. Wu CH, Fallini C, Ticozzi N, Keagle PJ, Sapp PC, Pitrowska K, et al. Mutations in the profilin gene cause Familial Amyotrophic Lateral sclerosis. Nature. 2012; 488: 499.
35. Blasco H, Mavel S, Corcia P, Gordon OH. The glutamate hypothesis in ALS: pathophysiology and drug development. Curr Med Chem. 2014; 21: 3551-3575.
36. Ikenaka K, Katsuno M, Kawai K, Ishigaki S, Tanaka F, Sobue G. Disruption of axonal transport in motor neurons diseases. Int J Mol Sci. 2012; 13: 1225-1238.
37. Obrador E, Salvador R, Estrela JM, Lopez-Blanch R, Jihad Jebbar A, Valldes SL. Oxidative stress, neuroinflammation and mitochondriain Oxidative stress pathophysiology of Amyotrophic Lateral sclerosis. Antioxidants. 2020; 9: 901.
38. Cheah BC, Vucic S, Krishnan A, Kiernan MC. Riluzole, neuroprotection and Amyotrophic Lateral sclerosis .Curr Med Chem. 2010; 17: 1949-1952.
39. Xu L, Guo YS, Liu YL, Wu SY, Yang C, Wu DX, et al. Oxidative stress in immune mediated motoneuron destruction. Brain Res. 2009; 1302: 225-232.
40. Reyes NA, Fisher JK, Austgen K, Vandensberg H, Huang EJ, Oakes SA. Blocking the mitochondrial apoptotic pathway preserves motor neurons viability and in a mouse model of Amyotrophic Lateral sclerosis. J Clin Investig. 2010; 120: 3673-3679.
41. Mc Caley ME, Baloh RH. Iinflammation in ALS/FTD pathogenesis. Acta Neuropathol. 2019; 137: 715.
42. Phillips T, Roberecht W. Neuroinflammation in Amyotrophic Lateral sclerosis: role of glial activationin motor neurons diseases. Lancet Neurol. 2011; 10: 253-263.
43. Haidet- Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, et al. Astrocytes from Familial and Sporadic ALS patients are toxic to motor neurons. Nat Biotechnol. 2011; 29: 824-828.
44. Tarafdar A, Pula G. The role of NADPH oxidases and Oxidative stress in neurodegenerative diseases. Int J Mol Sci. 2018; 19: 3824.
45. Swash M. Physical activity as a risk factor for ALS. J Neurol Neurosurg Psychiatry. 2018; 89: 793-803.
46. Visser AE, Rooney JPK, DOvidio F, Westenberg HJ, Vermeulen RCH, Beghi E, et al. Euromotor Consortium, et al. Multi cenre- cross cultural population based y case control study of physical activity as risk factor in Amyotrophic Lateral sclerosis. J Neurol Neurosurg Psychiatry. 2018; 89: 797-803.
47. Ben Zaken S, Nefussy B, Meckel Y, Eliakim A, Nemet D, Gotkine M, et al. Common genetic basis of ALS patients and soccer players may contribute to disease risk. Neurol Sci. 2022; 43: 4231-4238.
48. Beard JD, Kamel F. Military service, deployments and exposure in relation to Amyotrophic Lateral sclerosis etiology and survival. Epidemiol Rev. 2015; 37: 55-70.
49. Huisman MH, Seelen M, De Jong SW, Dorresteijn KR, Van Doormal PF, V Van der Kool AJ, et al. Lifetime Physical activity and the risk for Amyotrophic Lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013; 84: 976-981.
50. Cunha-Oliviera T, Montezinho I, Mendes C, Firzui O, Saso L, Oliviera PJ, Silva FSG. Oxidative stress in Amyotrophic Lateral sclerosis: pathophysiology and opportunities for Pharmacologic intervention. Oxid Med Cell Longev. 2020; 2020: 5021694.
51. Harwood CA, Westgate K, Gunstone S, Brage S, Wareham NJ, McDermott CJ, et al. Long term physical activity: an exogenous risk factor for Sporadic Amyotrophic Lateral sclerosis. Amyotrophic Lateral scler Front Degener. 2016; 17: 377.
52. Nijssen J, Comley LH, Hedlund E. Motor neurons vulnerability and resistance in Amyotrophic Lateral sclerosis. Acta Neuropathol. 2017; 133: 867.
53. Pehar M, Vargas MR, Cassina P, Barbietto AG, Beckman JS, Barbieto L. Complexity of astrocytes motor neurons interactions in Amyotrophic Lateral sclerosis .Neurodegen Dis. 2005; 2: 139-146.
54. Kulvinder Kochar Kaur, Allahbadia GN, Singh M. An Update on Further Progression of NAFLD, NASH with Prospective Therapies Like L-Carnitine (LC), Nicotinamide Ribose (NR) Combination, as well as Apical Sodium Dependent Bile Acids Transporter (ASBT) or Volixib at and Silybin as Alternatives. Int J Clin Med Cases. 2020; 3: 138.
55. Kulvinder Kochar Kaur, Allahbadia GN, Singh M. Have Probiotics and Synbiotics passed the test of time to be implemented in management of obesity and related metabolic disorders-a comprehensive review. Adv Obes Weight Manag Control. 2019; 9: 21-28.
56. Kulvinder Kochar Kaur, Allahbadia GN, Singh M. Will Probiotics Provide the Answer for Therapy of Non-alcoholic Fatty Liver Disease (NAFLD). A Systematic Review. Biochem Physiol. 2020; 9: 257.
57. Kulvinder Kochar Kaur, Allahbadia GN, Singh M. Therapeutic Clinical Implications of Crosstalk amongst Gut Microbiota, Bone Health and Vascular Calcification in Chronic Kidney Disease: A Narrative Review. J Endocrinol. 2023; 7: 1-19.
58. Kulvinder Kochar Kaur, Allahbadia GN, Singh M. An update on the Association of Gut-Liver Axis with Gut Microbiome Dysbiosis Correlated NAFLD along with NAFLD- HCC with Potential Therapeutic Approaches:a systematic review’’. Accepted for publication in Journal of Hepatology and Gastrointestinal Disorders. 2022.
59. Kulvinder Kochar Kaur, Allahbadia GN, Singh M. An update on role of mitochondrial transport in etiopathogenesis and management of various CNS diseases, neurodegenerative diseases, immune metabolic diseases, cancer, viral infections inclusive of COVID 19 disease-a systematic review. J Diab Metab Disorder Control. 2021; 8: 91-103.
60. Kulvinder Kochar Kaur, Allahbadia GN, Singh M. Are we any close to unraveling the mechanism of interactions among susceptibility genes towards Type 1 Diabetes, Gut Microbiota Along with Environmental factors, specifically early diet patterns –A Systematic Review’’. Endocrinology and Surgical Endocrinology. 2021; 2.
61. Kulvinder Kochar Kaur, Allahbadia GN, Singh M. Have we reached a time that therapeutic application of Gut Microbiota and Metabolites is feasible for avoidance and therapy of Osteoarthritis and bone correlated diseases:A Narrative Review. Curr Trends Biomedical Eng and Biosci. 2023; 21: 001-016.
62. Kulvinder Kochar Kaur, Allahbadia GN, Singh M. How can we Avoid the propagation of Neurode generative diseases: Aiming on Concentrating and targeting the risk factors like aging, oxida tive stress, inflammation, glycation along with vascular injury ‘’A Systematic Review’’. J of Anatomy and Physiology. 2021; 2: 17-32.
63. Fang P, Kazmi SA, Jameson KG, Hsiao EY. The Microbiome as amodifier of neurodegenerative diseases. Cell host Microbes. 2020; 28: 201.
64. Kulvinder Kochar Kaur, Allahbadia GN, Singh M. The association of dietary fatty acids and gut microbiota alterations in the development of neuropsychiatric diseases: A systematic review. Obes Res Open J. 2020; 7: 19-45.
65. Kulvinder Kochar Kaur, Allahbadia GN, Singh M. Advances in Probiotics use with the Utilization of Engineeringfor Diseases beyond Obesity, Non Alcoholic FattyLiver Disease, to Treat Neurodegenerative Diseases, MetabolicDiseases like Type1 Diabetes, Infectious Diseases and Infections-A Systematic ReviewJ Endocrinol. 2020; 4: 1-12.
66. Kulvinder Kochar Kaur, Allahbadia GN, Singh M. The importance of Dysbiosis in Intestinal flora Subsequent to ischaemic Stroke: Implications in Therapeutic Management and Biomarkers for Prognosis-ANarrative Review’’.
67. Mittal R, Debs LH, Patel AP, Nguyen D, Patel K, OConnor G, et al. Neurotransmitters: the critical modulators regulating gut- Brain axis. J Cell Physiol. 2017; 232: 2359.
68. Biagi E, Franceschi C, Rampelli S, Severgnini M, Ostan R, Turroni S, et al. Gut microbiota and extreme longevity. Curr Biol. 2016; 26:1480-1485.
69. Iatensko I, Boqueto JP, Lemaitre B. Microbiota derived lactate activates Reactive oxygen species (ROS), by the Intestinal NADPH Oxidase Nox and shortens drosophila lifespan. Immunity. 2018; 49: 929-942.e5.
70. Stebegg M, Silva-Cayetano A, Innocentin S, Jenkins TP, Cantessi C, Gilbert C, et al. Heterochronic Faecal transplantation boost gut germinal centers in aged mice. Nat Commun. 2019; 10: 2443.
71. Blacher E, Bashiardes S, Shapiro H, Rothscbild D, Mor U, Dori BachashM, et al. Potential roles of gut microbiome and in modulating ALS in mice. Nature. 2019; 572: 474-480.
72. Gotkine M, Kviatcotvsky D, Elianev E. Amyotrophic Lateral sclerosis and Intestinal microbiota- towards establishing cause and effect. Gut Microbe microbes. 2020; 11: 1833.
73. Zhang Y, O D, Garrett S, Xia Y, Sun J. Aberrant enteric neuromuscular system and dysbiosis in Amyotrophic Lateral sclerosis. Gut Microbes. 2021; 13: 1996848.
74. Neumann M, Kwong LK, Sampathu DM, Trojanowski JQ, Lee VM. TDP43 proteinopathy in frontotemporal degeneration and Amyotrophic Lateral sclerosis: protein misfolding disease without amyloidosis. Arch Neurol. 2007; 64: 1388-1394.
75. Soraru G, Orsetti V, Buratti E, Baralle F, Cima V, Volpe M, et al. TDP43 in skeletal muscle of patients affected with Amyotrophic Lateral sclerosis. Amyotrophic Lateral Scler. 2010; 11: 240-243.
76. Riva N, Gentile F, Cerri F, Gallia F, Podini P, Dina G, et al. Phosphorylated TDP43 aggregates in peripheral motor nerves of patients with Amyotrophic Lateral sclerosis. Brain. 2022; 145: 276-284.
77. Pattle SB, OShaughnessy J, Kantelberg O, Rifrai OM, Pate J, Nellaney K, et al. TDP43 aggregates accumulate in non-central nervous system tissues prior to symptoms onset in Amyotrophic Lateral sclerosis:a case series linking archival surgical biopsieswith Clinical phenotypic data. J Pathol Clin Res. 2023; 9: 44-55.
78. Fricker RA, Green EL, JSenkins L, Griffins SM. The influence of nicotinamide on health and disease in the central nervous system. Int J Tryptophan Res. 2018; 11: 117864691877665.
79. Fung TC, Olson C, Hsiao EY. Interactions between the microbiota, immune and the nervous system in health and disease. Nat Neurosci. 2017; 20: 145.
80. Martins, Battistini C, Sun JM. Gut feeling in Amyotrophic Lateral sclerosis: microbiome of mice and man. Front Cell Infect Microbiol. 2022; 12: 839526.
81. Liu J, Wang F. Role of neuroinflammation in Amyotrophic Lateral sclerosis: cellular mechanisms and therapeutic implications. Front Immunol. 2017; 8: 1005.
82. Pellegrini C, Antonioli L, Colucci R, Blandizzi C, Fornai M. Inter play among Gut microbiota, Intestinal mucosal barrier and e neuro immune system: a common path to a neurodegenerative disease?. Acta Neuropathol. 2018; 136: 3453-61.
83. Anderson G. Amyotrophic Lateral sclerosis pathoetiology and pathophysiology: roles of astrocytes, gutmicrobiome and muscle interactions via the mitochondrial melatonergic pathways with disruption by glyphosate based herbicides. Int J Mol Sci. 2023; 24: 587.
84. Kulvinder Kochar Kaur, Allahbadia GN, Singh M. Are we any Close to Utilizing Targeting SIRT Signalling Pathway for Enhancing the Oocyte Quality in Women with Advanced Maternal age: Bringing from Bench to Bedside: A Narrative Review. J Gynecol. 2023; 8: 1-17.
85. Xeng C, Huang X, Wang D, Yu D, Hou S, Cui H, et al. Role of Bile Acids signalling in neuromodulation under physiological and pathological conditions,. Cell Biosci. 2023; 11: 106.